Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.89)
# 1,684
Out of 4,711 analysts
2
Total ratings
100%
Success rate
30.46%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $7.24
Upside: +38.12%